1. Home
  2. BDSX vs EGHT Comparison

BDSX vs EGHT Comparison

Compare BDSX & EGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • EGHT
  • Stock Information
  • Founded
  • BDSX 2005
  • EGHT 1987
  • Country
  • BDSX United States
  • EGHT United States
  • Employees
  • BDSX N/A
  • EGHT N/A
  • Industry
  • BDSX Precision Instruments
  • EGHT EDP Services
  • Sector
  • BDSX Health Care
  • EGHT Technology
  • Exchange
  • BDSX Nasdaq
  • EGHT Nasdaq
  • Market Cap
  • BDSX 257.0M
  • EGHT 250.2M
  • IPO Year
  • BDSX 2020
  • EGHT 1997
  • Fundamental
  • Price
  • BDSX $1.69
  • EGHT $2.01
  • Analyst Decision
  • BDSX Strong Buy
  • EGHT Buy
  • Analyst Count
  • BDSX 4
  • EGHT 6
  • Target Price
  • BDSX $3.08
  • EGHT $2.83
  • AVG Volume (30 Days)
  • BDSX 222.0K
  • EGHT 832.3K
  • Earning Date
  • BDSX 11-05-2024
  • EGHT 10-30-2024
  • Dividend Yield
  • BDSX N/A
  • EGHT N/A
  • EPS Growth
  • BDSX N/A
  • EGHT N/A
  • EPS
  • BDSX N/A
  • EGHT N/A
  • Revenue
  • BDSX $60,902,000.00
  • EGHT $723,565,000.00
  • Revenue This Year
  • BDSX $48.06
  • EGHT $0.85
  • Revenue Next Year
  • BDSX $29.97
  • EGHT $2.15
  • P/E Ratio
  • BDSX N/A
  • EGHT N/A
  • Revenue Growth
  • BDSX 46.25
  • EGHT N/A
  • 52 Week Low
  • BDSX $1.15
  • EGHT $1.51
  • 52 Week High
  • BDSX $2.21
  • EGHT $3.92
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 44.40
  • EGHT 54.65
  • Support Level
  • BDSX $1.66
  • EGHT $1.89
  • Resistance Level
  • BDSX $1.80
  • EGHT $2.08
  • Average True Range (ATR)
  • BDSX 0.07
  • EGHT 0.09
  • MACD
  • BDSX -0.00
  • EGHT 0.03
  • Stochastic Oscillator
  • BDSX 38.46
  • EGHT 78.13

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About EGHT 8x8 Inc

8x8 Inc provides contact-center-as-a-service and unified-communications-as-a-service software applications to approximately 2.5 million users. The company's unified platform enables omnichannel communication to assist employees in communicating across voice, video, text, chat, and contact centers. The Company also generates revenue from sales of hardware and professional services, which are complementary to the delivery of its integrated technology platform.. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: